Thirty-five of the women successfully treated with rosoxacin harboured penicillinase-producing strains of N gonorrhoeae (PPNG) and 46 non-penicillinase-producing (non-PPNG) strains. Fifty of the women treated with spectinomycin had PPNG strains and 59 non-PPNG strains. Mild selflimiting side effects, principally dizziness, occurred in varying frequency with rosoxacin, but these were difficult to evaluate owing to the characteristics of the patient population and the conditions under which the study was conducted.
Introduction
Patients and methods
The emergence in 1957 of gonococcal strains with decreased sensitivity to penicillin' 2 and in 1979 of penicillinase-producing Neisseria gonorrhoeae (PPNG)3 4 together with recent reports of spectino- In all but three instances, these side effects were mild and self-limiting. In all but one of the patients they affected the central nervous system: dizziness in 53, vertigo in 20, drowsiness in 17, headache in 19, euphoria in two, and hallucination in one. In addition, two patients taking a single dose of 300 mg had blurred vision. Nausea was reported by five patients taking a single dose of 300 mg, three a split dose of 300 mg, and two a single dose of 200 mg. Most patients with dizziness had mild symptoms and only those taking a single dose of 300 mg (three patients) reported "severe" dizziness. Apart from this there was no correlation between the intensity of the dizziness and the dose of rosoxacin. In most patients the duration of dizziness was less than four hours with all regimens. The incidence of more prolonged dizziness (over four hours) was not correlated with dosage. The symptoms were generally well tolerated and no treatment or restriction of activity was required. No changes in vital signs or physical findings occurred that were thought to be related to the drug. This study was undertaken in a locality where PPNG accounts for 30-40% of gonococcal infections,'3-'5 which could not have been eradicated by penicillin treatment. This high incidence has led to the increased use of spectinomycin, which may result in the selection of spectinomycin-resistant mutants.7 16 17 Our findings showed that rosoxacin, either in a 200-mg single dose, 300-mg single dose, or 300-mg split dose, compared favourably with spectinomycin in the treatment of uncomplicated gonorrhoea in women. Since rosoxacin may be given orally in a single dose it appears to be a reasonable alternative to spectinomycin, particularly when penicillin-resistant gonorrhoea is prevalent.
An obvious disadvantage of this drug is the high incidence of side effects, as seen in this study. The apparent incidence appeared to increase with dosage. The frequency of apparent side effects in the doubleblind tolerance study, however, was about one-half that in the open-dose study among patients who received the same 300-mg single dose of rosoxacin. The discrepancy between these two groups, studied under the same conditions and taking the same dosage, cannot be explained, and may well illustrate the difficulty in drawing conclusions from these findings. Moreover, the incidence of reported side effects in this study was much higher than that found in other studies conducted in several hundred patients in Europe, the USA, South America, and other Asian countries (unpublished data). In addition, a lower incidence of side effects of 140% was noted in Filipino men receiving a 300-mg single dose in a concurrent study. 18 Although the difference in mean body weights between the male and female Filipinos (65 6 kg compared with 47*5 kg respectively) might be considered to be a contributory factor, there appeared to be no correlation between apparent side effects and body weight within the group of women receiving a single dose of 300 mg rosoxacin. The mean body weight in those reporting notable side effects was 46 7 kg compared with 46-2 kg in those with no or negligible apparent side effects. Thus, the influence of body weight is not clear.
The evaluation of these apparent side effects, primarily dizziness, was difficult because of the very nature of the study population and the methods used to determine them. These limitations were to be expected since the study was undertaken among prostitutes, who are highly susceptible to suggestion and yet in whom only direct questioning could be used to obtain answers about side effects. The fact that alcohol and drug abuse are indispensible features of their profession prevent any definitive conclusions about the frequency, type, and intensity of side effects attributable to rosoxacin in this study, since by themselves these two abuses may account for some of the side effects complained of. What is clear is that the side effects are generally mild and selflimiting.
